Navigating the European Union market requires strict adherence to the in vitro diagnostic medical devices regulation. Transitioning from the legacy IVDD directive to the updated regulation eu 2017 746 introduces heightened scrutiny, rigorous performance evaluations, and a new risk-based classification system for manufacturers.
Partnering with an experienced EU IVDR Consultant ensures your diagnostic products meet all European quality and safety standards without costly delays. At Morulaa HealthTech, we provide end-to-end regulatory strategy to streamline your CE marking process. Our technical writers and regulatory experts assist in updating technical documentation, conducting gap analyses, and structuring robust Performance Evaluation Reports (PER).
Complying with modern in vitro diagnostic regulations demands proactive documentation optimization to clear Notified Body audits on the first attempt. Whether transitioning legacy IVDs or introducing novel diagnostic technologies to the European market, our specialized team bridges regulatory gaps and delivers targeted non-conformity remediation.
Ensure long-term access to the EU market under the official eu ivdr regulation. Contact Morulaa HealthTech today to optimize your technical files, fulfill GSPR mandates, and achieve seamless CE mark certification.